Brookfield Corp’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-39,263
Closed -$2.23M 772
2022
Q1
$2.23M Buy
39,263
+475
+1% +$25.2K 0.01% 379
2021
Q4
$2.04M Buy
+38,788
New +$2.11M 0.01% 327
2020
Q4
Sell
-23,591
Closed -$1.15M 542
2020
Q3
$1.15M Buy
23,591
+4,475
+23% +$241K 0.01% 291
2020
Q2
$1.06M Buy
+19,116
New +$1.11M 0.01% 281

Other funds holding NUVA

Brookfield Corp's NUVA Position: Q2 2022 in Review

Brookfield Corp sold out of NuVasive, Inc. (NUVA) in Q2 2022, closing a stake of 39,263 shares — an estimated $2.23M sold.

Brookfield Corp first reported a position in NUVA in Q2 2020 and held it in 4 quarters. The position peaked at $2.23M in Q1 2022. 236 funds tracked by Wall St. Rank hold NUVA as of Q2 2022.

  • Brookfield Corp reported no remaining NuVasive, Inc. position as of Q2 2022 after selling out during the quarter.
  • Brookfield Corp sold 39,263 NuVasive, Inc. shares in Q2 2022, an estimated $2.23M.
  • Brookfield Corp first reported a position in NuVasive, Inc. in Q2 2020 and held it in 4 quarters.
  • Brookfield Corp's NuVasive, Inc. position peaked at $2.23M in Q1 2022.
  • 236 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2022.

Based on Brookfield Corp's 13F filing for Q2 2022, filed 15 Aug 2022.